A transmembrane protein (TMEM) is a type of protein that spans biological membranes.
Many of them extend through the lipid bilayer of the plasma membrane but others are …

Despite the recent advances in chemotherapeutic treatments against cancer, some types of
highly aggressive and invasive cancer develop drug resistance against conventional …

Ovarian cancer is a disease with a poor prognosis and little progress has been made to
improve treatment. It is now recognized that there are several histotypes of ovarian cancer …

Ovarian cancer (OC) causes significant morbidity and mortality as neither detection nor
screening of OC is currently feasible at an early stage. Difficulty to promptly diagnose OC in …

Resistance to platinum-based chemotherapy is a major clinical challenge in ovarian cancer,
contributing to the high mortality-to-incidence ratio. Management of the platinum-resistant …

Background Ovarian cancer (OV) is the deadliest gynecological cancer. Transmembrane
protein 119 (TMEM119) has been reported as oncogene in several human cancers …

Purpose The TMEM196 protein, which comprises four membrane-spanning domains,
belongs to the TMEM protein family. TMEM196 was identified as a candidate tumor …

Background Primary or acquired chemoresistance is a key link in the high mortality rate of
ovarian cancer. There is no reliable method to predict chemoresistance in ovarian cancer …

Abstract Background/Aim Growing evidence indicates a significant role of long non-coding
RNA (lncRNA) nuclear-enriched abundant transcript 1 (NEAT1) in ovarian cancer, a …

Ovarian cancer is a silent killer and, due to late diagnosis and frequent chemo resistance in
patients, the primary cause of fatality amongst the various types of gynecological cancer …